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In Canada, cardiovirus isolates related to Saffold virus 
were detected in nasopharyngeal aspirates from 3 children 
with respiratory symptoms. Polyprotein sequence of the 
Can112051-06 isolate had 91.2% aa identity with Saffold 
virus; however, EF and CD loops of the viral surface varied 
substantially. 
T
he family Picornaviridae contains 9 genera: Enterovi-
rus, Hepatovirus, Rhinovirus, Kobuvirus, and Parecho-
virus infect humans, whereas Aphtovirus, Erbovirus, Tes-
chovirus, and Cardiovirus are animal pathogens (1). The 
genus Cardiovirus is divided into 2 species: Theiler viruses 
and the encephalomyocarditis viruses (EMCVs) (2–5). 
Although rats and mice are the natural hosts for EMCVs, 
these cardioviruses have been found to infect many animal 
species including pigs, rodents, elephants, macaques, and 
humans (6–9). Recently, a new cardiovirus provisionally 
named Saffold virus (SAF-V) was isolated from a stool 
sample of an 8-month-old girl with fever (10). This virus 
is believed to constitute a novel cardiovirus species and is 
more genetically related to Theiler-like virus than to other 
known cardioviruses (10). We report the identiﬁ  cation and 
characterization of 3 SAF-V isolates recovered from chil-
dren with respiratory symptoms.
The Patients
The ﬁ  rst patient was a 23-month-old girl who was re-
ferred on March 6, 2006, to a tertiary hospital for bilateral 
otitis media that had not responded to amoxicillin or later to 
cefprozil. She also had cough, rhinorrhea, and fever of 39°C. 
Her 5-month-old brother had similar clinical signs. Blood 
cultures were negative, as were antigen detection tests for 
inﬂ  uenza A and B viruses, the respiratory syncytial virus, 
and adenoviruses. After 24 hours, the girl was discharged 
with a diagnosis of bilateral acute otitis media secondary to 
a viral infection. A nasopharyngeal aspirate collected at the 
time of admission was inoculated onto different continuous 
cell lines including human lung adenocarcinoma (A-549); 
human rhabdosarcoma (RD); transformed human kidney 
(293); human colon adenocarcinoma (HT-29); human la-
ryngeal carcinoma (Hep-2); human foreskin ﬁ  broblast; 
mink lung; and Vero, MDCK, and rhesus monkey kidney 
(LLC-MK2) cells. Cultures were incubated for 3 weeks at 
37°C in 5% CO2. A viral isolate (Can112051-06) with cyto-
pathic effects (round cells) suggestive of a picornavirus was 
observed only in LLC-MK2 cells after 6 days of incubation 
(Figure 1). An immunoﬂ  uorescent assay that used the Pan-
Enterovirus Blend kit (Light Diagnostics, Levingston, UK) 
gave a moderate ﬂ  uorescent signal. Nucleic acid extracts 
from Can112051-06 were further analyzed with a multi-
plex real-time reverse transcription–PCR (RT-PCR) assay 
for common respiratory viruses (inﬂ  uenza A and B viruses, 
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Figure 1. A) Cytopathic effects (round cells) observed 6 days 
after infection of rhesus monkey kidney (LLC-MK2) cells (second 
passage) with the Can112051-06 Saffold virus–like cardiovirus 
strain. B) Uninfected LLC-MK2 cells. Magniﬁ  cation ×10.Saffold Cardioviruses in Children, Canada
human respiratory syncytial virus, and human metapneu-
movirus) (11) as well as RT-PCR assays for enteroviruses 
and parechoviruses (12); results were negative.
The supernatant from LLC-MK2–infected cells was 
treated with DNase and divided into 2 aliquots for DNA 
and RNA extractions by using the QIAamp Blood Mini Kit 
and QIAamp Viral RNA extraction kits (QIAGEN, Mis-
sissauga, Ontario, Canada), respectively. Nucleic acids 
were then used in the sequence-independent single-prim-
er ampliﬁ  cation method as described (13). Amplicons of 
800–1,200 bp obtained from RNA samples were cloned 
and sequenced.
Sequence determination of cloned amplicons followed 
by tBLASTx analysis showed similarity of Can112051-06 
sequences with the SAF-V VP4 and 2C sequences (data 
not shown). Subsequent PCR ampliﬁ  cations and sequenc-
ing reactions that used primers selected from our clones 
and the complete SAF-V genome sequence (GenBank ac-
cession no. EF165067) enabled us to determine the com-
plete polyprotein encoding region of the Can112051-06 
isolate (GenBank accession no. AM922293). This region 
was 6,879 nt long compared with 6,888 nt for the SAF-V 
polyprotein sequence; nucleotide identity between the 2 
strains was 82.5%. The Can112051-06 polyprotein com-
prised 2,293 aa compared with 2,296 aa for the SAF-V 
polyprotein; amino acid identity between the 2 strains was 
91.2%. Deletions of 1 aa in the VP2 and 2 in the VP1 pro-
teins were found in Can112051-06 with regard to the pro-
totype SAF-V strain. As expected, the Can112051-06 and 
SAF-V polyproteins contained 11 putative cleavage sites. 
The 8 aa ﬂ  anking these sites were conserved; 6 sites were 
identical in the 2 strains, whereas the remaining sites had 1- 
or 2-aa differences (Table 1). The resulting 12 proteins of 
Can112051-06 and SAF-V had 76.1%–100% aa identities 
(Table 2). The highest difference level was seen in the L 
peptide. In addition to the L peptide, some cardioviruses, in 
particular Theiler’s murine encephalomyelitis virus strains 
that are associated with persistent infections, contain an al-
ternate open reading frame (ORF), the so-called L* (14). 
As for the prototype SAF-V strain, the Can112051-06 puta-
tive L* ORF is unlikely to encode a protein because it has 
an ACG (instead of ATG) start codon (data not shown). In 
addition, contrasting with the SAF-V L*, which contained 
57 aa, the Can112051-06 L* sequence contained only 34 
aa. Comparison of the L* sequence of Can112051-06 with 
the ﬁ  rst 34 aa of the SAF-V L* sequence showed 60.6% 
identity (data not shown). Four small loops are exposed on 
the virion surface of cardioviruses; 2 are part of the VP2 EF 
loop structure, and 2 are part of the VP1 CD loop structure. 
The EF loop structure of Can112051-06, which contained 
55 aa (residues 274-328 of the polyprotein), had 61.8% aa 
identity with that of SAF-V (Figure 2, panel A). Similarly, 
the CD loop structure of Can112051-06, which contained 
40 aa (residues 712-751 of the polyprotein), had 67.5% aa 
identity with the SAF-V counterpart (Figure 2, panel B).
Other respiratory samples with picornavirus-like cyto-
pathic effects on LLC-MK2 cells and weakly immunoﬂ  uo-
rescent signals according to the Pan-Enterovirus Blend Kit 
were screened for cardiovirus SAF-V by using a speciﬁ  c 
RT-PCR assay targeting a 2A–2C encoding region (1,407 
nt, 469 aa). With use of this strategy, 2 more cases were 
noted in September 2006: 1 in a 19-month-old child hos-
pitalized for suspected bacteremia and a cold and 1 in a 
4-year-old child hospitalized for right lung pneumonia and 
otitis media. The 2A-2C aa sequences of these additional 
isolates were identical and shared 96.6% and 97.2% aa 
identities with the corresponding regions of Can112051-06 
and the prototype SAF-V, respectively.
Conclusions
Our ﬁ  ndings suggest a pathogenic role for SAF-V-like 
viruses in humans. Although the polyprotein sequences of 
the Can112051-06 strain and the original US strain were 
related, the EF and CD loop structures varied substantially 
(61.8% and 67.5% aa identities, respectively). For com-
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Table 1. Cleavage sites of Can112051-06 and prototype Saffold 
virus cardiovirus polyproteins* 
Cleavage site  Can112051-06  Saffold virus 
L / VP4  MEPQ / GNSN  MEPQ / GNSN 
VP4 / VP2  PLLM / DQNT  PLLM / DQNT 
VP2 / VP3  LEDQ / SPIP  LEAD / SPIP 
VP3 / VP1  YTPH / GVDN  YTPQ / GVDN 
VP1 / V2A  LELQ / NPIS  LELQ / DPIS 
2A / 2B  FQLQ / GGVL  FQLQ / GGVL 
2B / 2C  LQQQ / SPVR  LQQQ / SPIR 
2C / 3A  LVAQ / SPGN  LVAQ / SPGN 
3A / 3B  EGEQ / AAYS  EGEQ / AAYS 
3B / 3C  LDVQ / GGGK  LDVQ / GGGK 
3C / 3D  LIPQ / GAIV  LTPQ / GAIV 
*Can112051-06 GenBank accession no. AM922293; Saffold virus 
GenBank accession no. EF165067. 
Table 2. Amino acid identities between Can112051-06 and 
prototype Saffold virus proteins* 
Protein  % Identity 
L  76.1 
VP4 97.2
VP2 83.9
VP3 85.2
VP1 76.7
2A 95.8
2B 97.6
2C 96.6
3A 100
3B 95.0
3C 96.8
3D 97.0
*Can112051-06 GenBank accession no. AM922293; Saffold virus 
GenBank accession no. EF165067. parison, the EF and CD loop structure sequences of EMCV 
and Mengovirus (2 members of the EMCV species) have 
95.2% and 95.1% aa identities, respectively. The differ-
ence between time of isolation of SAF-V (1981) and the 
Can112051-06 strain (2006) is unlikely to be responsible 
for such a high level of sequence variation. We previously 
showed that the amino acid sequences of the VP0-VP1 
capsid region of Canadian human parechovirus 1 strains 
isolated from 1985 through 2004 had 89.2% to 97.5% 
identities (12). Because the EF and CD loop structures 
are exposed on the viral surface of cardioviruses and thus 
constitute an important site for recognition by neutralizing 
antibodies (15), Can112051-06 and the original SAF-V 
might represent different serotypes, although further se-
rologic studies are needed to conﬁ  rm this hypothesis. The 
implication of the weak immunoﬂ  uorescent signal seen in 
cardiovirus-infected cells stained with an enterovirus an-
tibody is uncertain because of the considerable difference 
between the capsid proteins of cardioviruses and enterovi-
ruses, which constitute 2 separate picornavirus genera.
In contrast to the initial recovery of this virus from a 
stool sample (10), our 3 strains were recovered from na-
sopharyngeal aspirate samples of children with fever and 
some other respiratory signs. The cardioviruses were the 
only pathogens identiﬁ  ed in these samples. Whether SAF-V 
and the related Canadian strains described in this study 
should be classiﬁ  ed as a new human Cardiovirus species 
or as a new clade within the Theilovirus species remains to 
be determined.
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Figure 2. Comparison of amino acid sequences 
of the A) EF loop structure (part of the VP2 
protein) and B) the CD loop structure (part of the 
VP1 protein) between Can112051-06 and other 
cardioviruses including Saffold virus (SAF-V), 
Theiler’s murine encephalomyelitis virus (TMEV), 
Theiler-like virus, encephalomyocarditis virus 
(EMCV), and Mengovirus. Amino acid differences 
between Can112051-06 and SAF-V are shaded.